Regeneron beats quarterly sales on COVID-19 drug demand
Go back to Regeneron beats quarterly sales on COVID-19 drug demand| Regeneron (NASDAQ: REGN) | Delayed: 810.31 -17.41 (2.1%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $827.72 | 52 Week High | $592.36 | |||
| Open | $814.36 | 52 Week Low | $325.35 | |||
| Day High | $821.17 | P/E | 212.68 | |||
| Day Low | $799.42 | EPS | $3.81 | |||
| Volume | 556,499 | |||||

